The Medical Alley Association announced today that it appointed Roberta Dressen as its new president and CEO. Dressen takes over the position previously held by Shaye Mandle since 2014 before he announced his departure for the Biotechnology Innovation Organization (BIO) in February. Steffen Hovard served as interim CEO in the time since then. Hovard will […]
Personnel Moves
Navidea Biopharmaceuticals makes board of directors changes
Navidea Biopharmaceuticals (NYSE:NAVB) announced today that it made a number of changes on its board of directors. Dublin, Ohio-based Navidea ‘s chair of the board and director S. Kathryn Rouan, along with director Claudine Bruck, retired from those positions, effective immediately. Get the full story at our sister site, Drug Delivery Business News.
Zimmer Biomet spinoff to be called ZimVie
Zimmer Biomet (NYSE:ZBH) announced today that the planned spinoff of its spine and dental businesses will be called ZimVie. Spokesperson Laura Driscoll elaborated that “Zim” derives from Zimmer Biomet, the new company’s roots — and “Vie” is the French word for “life,” symbolizing the future. (Abbott used a similar construct with its AbbVie pharma spinoff.) ZimVie’s […]
Augmedics appoints chief financial officer
Augmedics announced today that it appointed Raj Asarpota as its new EVP and CFO. Chicago-based Augmedics said in a news release that Asarpota, whose role becomes effective today, will lead the company’s global finance organization and be responsible for accounting, treasury, financial planning and analysis, tax and investor relations. The augmented reality-based imaging technology developer […]
Medtronic CFO Karen Parkhill honored for financial excellence
Medtronic CFO Karen Parkhill has been named as an outstanding finance executive by the Minneapolis/St. Paul Business Journal in Minnesota. Parkhill is one of 14 individuals who will be honored in the newspaper’s 2021 CFO of the Year awards in November. She was one of two winners in the public company category, joined by Piper […]
Ibex appoints new CMO, moves CEO to Boston to lead U.S. expansion
Ibex Medical Analytics announced today that it appointed Dr. Douglas Clark as its new chief medical officer. In addition to appointing Clark to its executive team, Ibex announced that co-founder & CEO Joseph Mossel will relocate to the U.S. to lead its North American expansion efforts from its Boston headquarters. Clark previously served as CMO […]
Lyra Therapeutics appoints new CFO
Lyra Therapeutics (NSDQ:LYRA) announced today that it appointed Jason Cavalier as its new chief financial officer, effective today. Cavalier succeeds the company’s current CFO, Don Elsey, who is retiring while he remains expected to serve in an advisory role to assist with the transition. Get the full story at our sister site, Drug Delivery Business News.
iRhythm picks Dexcom COO Quentin Blackford as new CEO
iRhythm Technologies (NSDQ:IRTC) announced today that it appointed Quentin Blackford as its new president & CEO. Blackford will assume the role of president & CEO and become a member of the company’s board of directors effective Oct. 4, 2021. The company had been searching for a CEO since June when Mike Coyle announced that he […]
Corin Group picks head of Medtronic’s spine business as its CEO
Corin Group announced today that it appointed former Medtronic executive Jacob Paul as its new CEO. Cirencester, U.K.–based Corin Group said in a news release that Paul “brings unparalleled strategic and operational experience” to the company and is “well placed” to lead it through the next phase of its mission to improve patient activity and […]
NuVasive creates new C-level positions
NuVasive (NSDQ:NUVA) announced that it added chief commercial officer and chief technology officer as new executive leadership roles. Effective immediately, Massimo Calafiore will assume the position of chief commercial officer, while Ryan Donahoe was appointed as chief technology officer, with both reporting directly to CEO J. Christopher Barry. In connection with the new leadership structure, […]
Report: Two vaccine leaders set to step down from FDA
Two senior vaccine leaders within the FDA are reportedly relinquishing their positions within the administration. According to a report from Endpoints News, which cites a letter released internally to FDA staff first reported on by BioCentury, Marion Gruber and Phil Krause will depart in the coming months due to frustrations over the delegation of certain decisions within some governing […]
